The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology
Open accessAbstract
Alzheimer's disease (AD) is characterized by loss of specific cell populations within selective subregions of the hippocampus. Excitotoxicity, mediated via ionotropic glutamate receptors, may play a crucial role in this selective neuronal vulnerability. We investigated whether alterations in NMDA receptor subunits occurred during AD progression. Employing biochemical and in situ hybridization techniques in subjects with a broad range of AD pathology, protein levels, and mRNA expression of NR1/2A/2B subunits were assayed. With increasing AD neuropathology, protein levels and mRNA expression for NR1/2B subunits were significantly reduced, while the NR2A subunit mRNA expression and protein levels were unchanged. Cellular analysis of neuronal mRNA expression revealed a significant increase in the NR2A subunit in subjects with moderate neurofibrillary tangle neuropathology. This investigation supports the hypothesis that alterations occur in the expression of specific NMDA receptor subunits with increasing AD pathologic severity, which is hypothesized to contribute to the vulnerability of these neurons.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GluN2A and GluN2B expression levels (mRNA and protein) were also found to decrease in vulnerable brain regions, including the hippocampus and cerebral cortex in AD [62].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [62]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
The physiology of excitatory amino acids in the vertebrate central nervous system
Mayer, M. L., & Westbrook, G. L. (1987) · Progress in Neurobiology · doi:10.1016/0301-0082(87)90011-6 · Cited by 1,711
Mattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,633
Molecular diversity of the NMDA receptor channel
Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Hisashi, M., Kumanishi, T., Arakawa, M., et al. (1992) · Nature · doi:10.1038/358036a0 · Cited by 1,352
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.
Ishii, T. M., Moriyoshi, K., Sugihara, H., Sakurada, K., Kadotani, H., Yokoi, M., Akazawa, C., Shigemoto, R., Mizuno, N., & Masu, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53849-7 · Cited by 980
N-methyl-D-aspartic acid receptor structure and function
McBain, C. J., & Mayer, M. L. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.3.723 · Cited by 976
Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907
Functional and Pharmacological Differences Between Recombinant N -Methyl- d -Aspartate Receptors
Vicini, S., Wang, J. F., Li, J. H., Zhu, W. J., Wang, Y. H., Luo, J. H., Wolfe, B. B., & Grayson, D. R. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.2.555 · Cited by 674
Self-citationBall, M. J. (1977) · Acta Neuropathologica · doi:10.1007/bf00692056 · Cited by 639
β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
Koh, J., Yang, L. L., & Cotman, C. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91355-k · Cited by 617
Duvernoy, H. M., Cattin, F., & Risold, P. (2013) · Springer eBooks · doi:10.1007/978-3-642-33603-4 · Cited by 569
Laube, B., Hirai, H., Sturgess, M., Betz, H., & Kuhse, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81249-0 · Cited by 476
Luo, J., Wang, Y., Yasuda, R. P., Dunah, A. W., & Wolfe, B. B. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.79 · Cited by 399
Self-citationKuryatov, A. (1994) · Neuron · doi:10.1016/0896-6273(94)90445-6 · Cited by 385
Gao, X.-M., Sakai, K., Roberts, R. C., Conley, R. R., Dean, B., & Tamminga, C. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1141 · Cited by 381
Dementia of the Alzheimer's Type: Changes in Hippocampal L‐[ 3 H]Glutamate Binding
Greenamyre, J. T., Penney, J. B., D’Amato, C. J., & Young, A. B. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb04127.x · Cited by 278
Priestley, T., Laughton, P., Myers, J., Bourdellès, B. L., Kerby, J., & Whiting, P. J. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10541-5 · Cited by 262
Functional Neurobiology of Aging
(2001) · Elsevier eBooks · doi:10.1016/b978-0-12-351830-9.x5000-8 · Cited by 246
Hirai, H., Kirsch, J., Laube, B., Betz, H., & Kuhse, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6031 · Cited by 221
Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease
Geddes, J. W., Chang-Chui, H., Cooper, S. M., Lott, I. T., & Cotman, C. W. (1986) · Brain Research · doi:10.1016/0006-8993(86)90611-6 · Cited by 210
Anson, L. C., Chen, P. E., Wyllie, D. J. A., Colquhoun, D., & Schoepfer, R. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00581.1998 · Cited by 209
Chazot, P. L., Coleman, S. K., Cik, M., & Stephenson, F. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51098-5 · Cited by 198
Jansen, K. L. R., Faull, R. L. M., Dragunow, M., & Synek, B. J. L. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90246-z · Cited by 197
Wang, Y., Bosy, T. Z., Yasuda, R. P., Grayson, D. R., Vicini, S., Pizzorusso, T., & Wolfe, B. B. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010176.x · Cited by 160
Self-citationSze, C., Bi, H., Kleinschmidt-DeMasters, B. K., Filley, C. M., & Martin, L. J. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00467-6 · Cited by 146
Brorson, J. R., Bindokas, V. P., Iwama, T., Marcuccilli, C. J., Chisholm, J. C., & Miller, R. J. (1995) · Journal of Neurobiology · doi:10.1002/neu.480260305 · Cited by 129
β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus
Wu, J., Anwyl, R., & Rowan, M. J. (1995) · Neuroreport · doi:10.1097/00001756-199511270-00031 · Cited by 128
Dual-component miniature excitatory synaptic currents in rat hippocampal CA3 pyramidal neurons
McBain, C. J., & Dingledine, R. J. (1992) · Journal of Neurophysiology · doi:10.1152/jn.1992.68.1.16 · Cited by 121
Hawkins, L. M., Chazot, P. L., & Stephenson, F. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27211 · Cited by 112
Penney, J. B., Maragos, W. F., Greenamyre, J. T., Debowey, D. L., Hollingsworth, Z. R., & Young, A. B. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.4.314 · Cited by 98
Rigby, M., Bourdellès, B. L., HEAVENS, R. P., Kelly, S., Smith, D. W., Butler, A., Hammans, R., Hills, R., Xuereb, J. H., Hill, R., et al. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00089-9 · Cited by 93
Ikonomović, M. D., Mizukami, K., Davies, P., Hamilton, R. L., Sheffield, R., & Armstrong, D. M. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199709000-00007 · Cited by 82
Self-citationRegional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease
Cowburn, R. F., Hardy, J., Roberts, P., & BRIGGS, R. S. J. (1988) · Brain Research · doi:10.1016/0006-8993(88)90048-0 · Cited by 82
Ułas, J., Brunner, L. C., Geddes, J. W., Choe, W. S., & Cotman, C. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90075-d · Cited by 75
Yasuda, R. P., Ikonomovic, M. D., Sheffield, R., Rubin, R. T., Wolfe, B. B., & Armstrong, D. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00178-s · Cited by 71
Self-citationKosinski, C. M., Standaert, D. G., Counihan, T. J., Scherzer, C. R., Kerner, J. A., Daggett, L. P., Veli�elebi, G., Penney, J. B., Young, A. B., & Landwehrmeyer, G. B. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980105)390:1 · Cited by 62
Chapter 4 Excitotoxin-mediated neuron death in youth and old age
Olney, J. W. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)63165-9 · Cited by 60
Rissman, R. A., Mishizen-Eberz, A. J., Carter, T. L., Wolfe, B. B., Blas, A. L. D., Miralles, C. P., Ikonomović, M. D., & Armstrong, D. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00030-7 · Cited by 59
Self-citationIs senile dementia of the Alzheimer type associated with hippocampal plasticity?
Represa, A., Duyckaerts, C. J., Tremblay, E. C., Hauw, J., & Ben‐Ari, Y. (1988) · Brain Research · doi:10.1016/0006-8993(88)90706-8 · Cited by 58
Amyloid β-protein fragment 25–35 causes activation of cytoplasmic calcium in neurons
Joseph, R., & Han, E. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80044-0 · Cited by 58
Ikonomović, M. D., Mizukami, K., Warde, D., Sheffield, R., Hamilton, R. L., Wenthold, R. J., & Armstrong, D. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7196 · Cited by 57
Self-citationAronica, E., Dickson, D., Kress, Y., Morrison, J. H., & Zukin, R. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00260-1 · Cited by 56
Ułas, J., & Cotman, C. W. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00023-7 · Cited by 51
Ikonomović, M. D., Sheffield, R., & Armstrong, D. M. (1995) · Hippocampus · doi:10.1002/hipo.450050509 · Cited by 48
Self-citationPlasticity in hippocampal excitatory amino acid receptors in Alzheimer's disease
Geddes, J. W., & Cotman, C. W. (1986) · Neuroscience Research · doi:10.1016/0168-0102(86)90062-3 · Cited by 46
Amyloid β-peptide(25-35) changes [Ca2+] in hippocampal neurons
Mogensen, H. S., Beatty, D. M., Morris, S. J., & Jørgensen, O. S. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00057 · Cited by 46
Expression of the NMDA R1 receptor in selected human brain regions
Böckers, T. M., Zimmer, M., Müller, A., Bergmann, M., Brose, N., & Kreutz, M. R. (1994) · Neuroreport · doi:10.1097/00001756-199404000-00028 · Cited by 43
Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain
Wang, Y., TesFaye, E., Yasuda, R. P., Mash, D. C., Armstrong, D. M., & Wolfe, B. B. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00111-x · Cited by 38
Self-citationMizukami, K., Grayson, D. R., Ikonomović, M. D., Sheffield, R., & Armstrong, D. M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00347-1 · Cited by 37
Self-citationGlutamate Receptors in Aging and Alzheimer's Disease
Mishizen-Eberz, A. J., Ikonomović, M. D., & Armstrong, D. M. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50022-6 · Cited by 18
Self-citationBel, E. A. D., & Slater, P. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90340-y · Cited by 17
Cited by
Sorted by citations
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease
Bezprozvanny, I., & Mattson, M. P. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.005 · Cited by 938
Selective vulnerability in neurodegenerative diseases
Fu, H., Hardy, J., & Duff, K. E. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0221-2 · Cited by 585
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
Metadata
- Authors
- Mishizen-Eberz, A. J., Rissman, R. A., Carter, T. L., Ikonomovic, M. D., Wolfe, B. B., & Armstrong, D. M.
- Affiliations
- Lankenau Institute for Medical Research (US)
- Georgetown University Medical Center (US)
- Corresponding author
- Mishizen-Eberz, Amanda J
- ORCID
- Rissman, Robert A
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 15
- Issue
- 1
- Pages
- 80-92
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2024849224
- Cited by
- 156
- References
- 55
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 9 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 12 · 2013: 7 · 2012: 6
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- green
- doaj.org
- Licence
- Locations
- Neurobiology of Disease (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (5r01ag008206-15)
- National Institute on Aging (AG 08206)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, NMDA receptor subunits, NR1, NR2A, NR2B, hippocampus, excitotoxicity, ionotropic glutamate receptors, neurofibrillary tangles, selective neuronal vulnerability, mRNA expression, protein abundance, disease progression
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Hippocampus, Humans, Immunohistochemistry, Male, Middle Aged, Neurons, RNA, Messenger, Down-Regulation, Up-Regulation, Receptors, N-Methyl-D-Aspartate, Neurofibrillary Tangles, Disease Progression, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review